SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-178875"
 

Search: onr:"swepub:oai:DiVA.org:uu-178875" > MYC+ diffuse large ...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Cuccuini, Wendy (author)

MYC+ diffuse large B-cell lymphoma is not salvaged by classical R-ICE or R-DHAP followed by BEAM plus autologous stem cell transplantation

  • Article/chapterEnglish2012

Publisher, publication year, extent ...

  • American Society of Hematology,2012
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-178875
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-178875URI
  • https://doi.org/10.1182/blood-2012-01-406033DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Approximately 5-10% of diffuse large B-cell lymphomas (DLBCL) harbor a 8q24/MYC rearrangement (MYC+). We determined the prognostic significance of MYC rearrangement in patients with relapsed/refractory DLBCL prospectively treated by R-ICE or R-DHAP followed by highdose therapy and autologous stem cell transplantation. Twenty-eight (17%) of the 161 patients analyzed presented a MYC+ rearrangement, targeted as either simple hit (25%) or complex hits (n = 75%) including MYC/BCL2, MYC/BCL6, and MYC/BCL2/BCL6. Results were statistically highly concordant in matched primary and relapsed biopsies (n = 45). Compared to the MYC+ DLBCL patients, the MYC+ DLBCL patients presented with a more elevated lactico-deshydrogenase level (P = .0006) and a more advanced age adjusted international prognostic index (P = .0039). The 4-year PFS and OS were significantly lower in the MYC+ DLBCL patients than those in the MYC- DLBCL patients, with rates of 18% vs 42% (P = .0322), and of 29% vs 62% (P = .0113), respectively. Type of treatment, R-DHAP or R-ICE, had no impact on survivals, with 4-year PFS rates of 17% vs 19% and 4-year OS rates of 26% vs 31%. In conclusion, MYC rearrangement is an early event in DLBCL. MYC+ DLBCL patients have a significant inferior prognosis than MYC- DLBCL patients. Their outcome was not influenced by the proposed salvage therapy.

Added entries (persons, corporate bodies, meetings, titles ...)

  • Briere, Josette (author)
  • Mounier, Nicolas (author)
  • Voelker, Hans-Ullrich (author)
  • Rosenwald, Andreas (author)
  • Sundström, ChristerUppsala universitet,Molekylär och morfologisk patologi(Swepub:uu)chrisund (author)
  • Cogliatti, Sergio (author)
  • Hirchaud, Edouard (author)
  • Ysebaert, Loic (author)
  • Bron, Dominique (author)
  • Soulier, Jean (author)
  • Gaulard, Philippe (author)
  • Houlgatte, Remi (author)
  • Gisselbrecht, Christian (author)
  • Thieblemont, Catherine (author)
  • Uppsala universitetMolekylär och morfologisk patologi (creator_code:org_t)

Related titles

  • In:Blood: American Society of Hematology119:20, s. 4619-46240006-49711528-0020

Internet link

Find in a library

  • Blood (Search for host publication in LIBRIS)

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view